This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schachter, J.
Right arrow Articles by Lorincz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schachter, J.
Right arrow Articles by Lorincz, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1999, p. 3668-3671, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Ability of the Digene Hybrid Capture II Test To Identify Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Specimens

Julius Schachter,1,* Edward W. Hook III,2 William M. McCormack,3 Thomas C. Quinn,4 Max Chernesky,5 Sylvia Chong,5 Jennifer I. Girdner,4 Paula B. Dixon,2 Lynette DeMeo,3 Eva Williams,1 Allison Cullen,6 and Attila Lorincz6

Chlamydia Research Laboratory, Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California1; Division of Infectious Diseases, University of Alabama, Birmingham, Alabama2; Division of Infectious Diseases, State University of New York, Brooklyn, New York3; Division of Infectious Diseases, Johns Hopkins University, Baltimore,4 and Digene Corporation, Silver Spring,6 Maryland; and St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

Received 17 March 1999/Returned for modification 1 June 1999/Accepted 9 August 1999

The Digene Hybrid Capture II (HCII CT/GC) test is a combination test designed to detect Chlamydia trachomatis and Neisseria gonorrhoeae in a single specimen. It is a nucleic acid hybridization test which uses signal amplification to increase sensitivity. We compared its performance to that of culture on cervical specimens from 1,370 women. Direct fluorescent-antibody assay was used to resolve discrepant results for C. trachomatis. Samples were collected with a proprietary cervical brush or with endocervical swabs. The HCII CT/GC test proved to be sensitive and specific in detecting these organisms. Compared to N. gonorrhoeae culture, it had a sensitivity of 93% (87/94) and a specificity of 98.5% (1,244/1,263). Compared to C. trachomatis culture, the sensitivity was 97.7% (129/132) and specificity was 98.2% (1,216/1,238). Testing of some specimens with discrepant results by PCR suggested that the test would actually prove to be even more specific if it were compared to a nucleic acid amplification test (NAAT). The sensitivity of C. trachomatis culture was somewhat less, at 88.6% (117/132). The endocervical brush appeared to be better than Dacron swabs for collecting specimens. The HCII CT/GC test offers an attractive format that allows simultaneous detection of C. trachomatis and N. gonorrhoeae with a single specimen. An initial positive result is followed by repeat tests with probes to identify chlamydiae or gonococci. This test is more sensitive than C. trachomatis culture and is at least as sensitive as culture for gonococci. It deserves further evaluation and comparison with NAATs and may well offer an attractive alternative for diagnosis and screening of these infections.


* Corresponding author. Mailing address: Chlamydia Research Laboratory, Department of Laboratory Medicine, University of California, San Francisco, 1001 Potrero Ave., SFGH 3416, San Francisco, CA 94110. Phone: (415) 824-5115. Fax: (415) 821-8945. E-mail: jsch{at}itsa.ucsf.edu.


Journal of Clinical Microbiology, November 1999, p. 3668-3671, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Munson, E., Boyd, V., Czarnecka, J., Griep, J., Lund, B., Schaal, N., Hryciuk, J. E. (2007). Evaluation of Gen-Probe APTIMA-Based Neisseria gonorrhoeae and Chlamydia trachomatis Confirmatory Testing in a Metropolitan Setting of High Disease Prevalence. J. Clin. Microbiol. 45: 2793-2797 [Abstract] [Full Text]  
  • Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., Jimenez, S. E., Lowy, D. R., for the Costa Rican HPV Vaccine Trial Group, (2007). Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection: A Randomized Trial. JAMA 298: 743-753 [Abstract] [Full Text]  
  • Marshall, R., Chernesky, M., Jang, D., Hook, E. W., Cartwright, C. P., Howell-Adams, B., Ho, S., Welk, J., Lai-Zhang, J., Brashear, J., Diedrich, B., Otis, K., Webb, E., Robinson, J., Yu, H. (2007). Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 45: 747-751 [Abstract] [Full Text]  
  • Schachter, J., Chow, J. M., Howard, H., Bolan, G., Moncada, J. (2006). Detection of Chlamydia trachomatis by Nucleic Acid Amplification Testing: Our Evaluation Suggests that CDC-Recommended Approaches for Confirmatory Testing Are Ill-Advised.. J. Clin. Microbiol. 44: 2512-2517 [Abstract] [Full Text]  
  • Whiley, D. M., Tapsall, J. W., Sloots, T. P. (2006). Nucleic Acid Amplification Testing for Neisseria gonorrhoeae: An Ongoing Challenge. J. Mol. Diagn. 8: 3-15 [Abstract] [Full Text]  
  • Shafer, M.-A., Moncada, J., Boyer, C. B., Betsinger, K., Flinn, S. D., Schachter, J. (2003). Comparing First-Void Urine Specimens, Self-Collected Vaginal Swabs, and Endocervical Specimens To Detect Chlamydia trachomatis and Neisseria gonorrhoeae by a Nucleic Acid Amplification Test. J. Clin. Microbiol. 41: 4395-4399 [Abstract] [Full Text]  
  • Shafer, M.-A. B., Tebb, K. P., Pantell, R. H., Wibbelsman, C. J., Neuhaus, J. M., Tipton, A. C., Kunin, S. B., Ko, T. H., Schweppe, D. M., Bergman, D. A. (2002). Effect of a Clinical Practice Improvement Intervention on Chlamydial Screening Among Adolescent Girls. JAMA 288: 2846-2852 [Abstract] [Full Text]  
  • Van Der Pol, B., Williams, J. A., Smith, N. J., Batteiger, B. E., Cullen, A. P., Erdman, H., Edens, T., Davis, K., Salim-Hammad, H., Chou, V. W., Scearce, L., Blutman, J., Payne, W. J. (2002). Evaluation of the Digene Hybrid Capture II Assay with the Rapid Capture System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 40: 3558-3564 [Abstract] [Full Text]  
  • Bachmann, L. H., Desmond, R. A., Stephens, J., Hughes, A., Hook III, E. W. (2002). Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women following Recommended Therapy for Uncomplicated Gonorrhea. J. Clin. Microbiol. 40: 3596-3601 [Abstract] [Full Text]  
  • Chernesky, M A (2002). Chlamydia trachomatis diagnostics. Sex. Transm. Infect. 78: 232-234 [Abstract] [Full Text]  
  • Darwin, L. H., Cullen, A. P., Arthur, P. M., Long, C. D., Smith, K. R., Girdner, J. L., Hook III, E. W., Quinn, T. C., Lorincz, A. T. (2002). Comparison of Digene Hybrid Capture 2 and Conventional Culture for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Specimens. J. Clin. Microbiol. 40: 641-644 [Abstract] [Full Text]